Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Operating expenses:
Research and development	$ 17,627	$ 12,523	$ 60,690	$ 35,125
General and administrative	5,595	5,239	19,079	14,609
Total operating expenses	23,222	17,762	79,769	49,734
Loss from operations	(23,222)	(17,762)	(79,769)	(49,734)
Other income (expense):
Interest income	622	105	1,255	333
Other expense:	(120)	(56)	(94)	(57)
Total other income	502	49	1,161	276
Net loss	$ (22,720)	$ (17,713)	$ (78,608)	$ (49,458)
Net loss per share, basic	$ (0.57)	$ (0.45)	$ (1.97)	$ (1.25)
Net loss per share, diluted	$ (0.57)	$ (0.45)	$ (1.97)	$ (1.25)
Weighted average shares used to compute net loss per share, basic	40,036,201	39,607,745	39,930,418	39,450,655
Weighted average shares used to compute net loss per share, diluted	40,036,201	39,607,745	39,912,038	39,450,655